Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry.

Nocturne, G; Dougados, M; Constantin, A; Richez, C; Sellam, J; Simon, A; Wendling, D; Mariette, X; Gottenberg, J-E

Nocturne, G; Dougados, M; Constantin, A; Richez, C; Sellam, J; Simon, A; Wendling, D; Mariette, X; Gottenberg, J-E.

Ann Rheum Dis ; 69(2): 471-2, 2010 Feb.

Article in En | MEDLINE | ID: mdl-20107035

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antirheumatic Agents/therapeutic use; Immunosuppressive Agents/therapeutic use; Spondylarthropathies/drug therapy; Antibodies, Monoclonal, Murine-Derived; Follow-Up Studies; Humans; Middle Aged; Off-Label Use; Rituximab; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antirheumatic Agents / Spondylarthropathies / Immunosuppressive Agents / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Humans / Middle aged Language: En Journal: Ann Rheum Dis Year: 2010 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google